COVID-19 Vaccines for 2025–2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians | Synapse
February 26, 2026
COVID-19 Vaccines for 2025–2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians
Puntos clave
The aim is to evaluate the need for updated COVID-19 vaccines for non-risk adults for the years 2025-2026.
Review of current vaccination strategies
Analysis of mRNA vaccine effectiveness
Recommendations based on adult age and health status
Adults aged 18 to 64 may benefit from updated mRNA vaccines in 2025-2026
Non-pregnant and non-immunocompromised adults are the focus of the recommendations
Resumen
Adults aged 18 to 64 years who are not at increased risk for severe COVID-19 may consider receiving an updated 2025-2026 mRNA-based COVID-19 vaccine.